Medicalook
Medicalook

Pulmicort

http://www.medicalook.com
Pulmicort

Pulmicort review





Pulmicort is generically prescribed as budesonide inhalation and is commonly used to treat the inflammation that causes asthma attacks. Pulmicort is used to prevent asthma attacks and is not considered a rescue inhaler. Pulmicort can lower the body’s ability to fight off infection and patients should be advised to avoid exposure to infectious diseases. Pulmicort is an inhaled steroid.

Most patients are able to take Pulmicort with few side effects, although those who experience common side effects do not report them to be bothersome enough to discontinue use of Pulmicort. Patients most often report dry or irritated nose, throat, or mouth, cough, sore throat, deepening voice, hoarseness, headaches, yeast infections of the mouth, other infections of the mouth, lightheadedness, an increase sense of pressure on the eyes, dizziness, fatigue, weakness, tanning of the skin, unpleasant taste in the mouth, unpleasant smell, loss of taste, loss of smell, nausea, abdominal discomfort, or weight loss. With long term use some patients experience tearing of the eyes, glaucoma, vision impairment correctable with glasses or contacts, stunted growth in children, cataracts, depression, aggression, anxiety, mood changes, or irritability, although rare.

In a smaller percentage of patients, more serious side effects may occur, which require medical assessment and often emergency medical attention. While rare, these side effects may include unexplained open sores, mysterious bruising, rash, numbness, pain, tingling, and difficulty breathing or worsening asthma symptoms.

A small percentage of patients starting Pulmicort experience an allergic reaction. An allergic reaction to Pulmicort is rare but requires immediate emergency medical intervention. An allergic reaction will present with hives, difficulty breathing, and swelling of the lips, mouth, tongue, or throat. These symptoms will occur suddenly immediately after use.

The prescribing physician should thoroughly assess the patient’s medical condition prior to prescribing Pulmicort. Patients with infections, whether they are viral infections, bacterial infections, or fungal infections, and regardless of whether the infection is bothersome should avoid the use of Pulmicort until after the infection has cleared.

The American Food and Drug Administration rated Pulmicort as a pregnancy risk category B, which means that there is not an expectation that this medication would cause harm or birth defects to a developing fetus. It has not yet been determined whether or not Pulmicort passes through the mother’s breast milk and affects a nursing baby.

Pulmicort is not an effective treatment for an asthma attack which is already in progress. Pulmicort is intended to prevent the occurrence of asthma attacks. If a patient experiences a greater need for their asthma medication, or has reached their limit on rescue inhaler doses within a 24 hour period, a physician should be contact at once. This may mean the asthma does not respond well to Pulmicort, or it could be a precursor to a serious asthma attack.

Patients should take Pulmicort as it has been prescribed and they should never alter their dose without speaking to a physician first. If a dose of Pulmicort is mistakenly missed, the patient should take the dose when it is remembered unless it is nearing time for the next scheduled dose, in which case the missed dose should be skipped. Patients should not take double doses of Pulmicort in the event of a missed dose to avoid a potential overdose. While an overdose is unlikely, if an overdose is suspected the patient should seek immediate medical care at the nearest emergency room. The effects of an overdose are unknown.

Patients should never take additional medications, whether prescription or over the counter, without first consulting with the pharmacist or physician, as some medications may interact with Pulmicort. Medications with known interactions with Pulmicort include antifungal medications, including topical medications. Patients should consult with the pharmacist or physician before taking supplemental vitamins, herbal remedies, or energy supplements.

Pulmicort has the following structural formula:

Chemical structure of pulmicort


• Molecular formula of pulmicort is C25H34O6
• Molecular weight is 430.534 g/mol
Pulmicort available : 0.25mg/2ml suspension 2ml plastic container, 0.5mg/2ml suspension 2ml plastic container

Generic name: Budesonide

Brand name(s): Bidien, Budeson, Cortivent, Desonide, Desowen, Entocort, Micronyl, Preferid, Rhinocort, Rhinocort Aqua, Spirocort, Tridesilon

  Your Pulmicort review